HC Wainwright Reaffirms “Buy” Rating for Quantum-Si (NASDAQ:QSI)

Quantum-Si (NASDAQ:QSI)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a report released on Monday,Benzinga reports. They presently have a $5.50 price objective on the stock. HC Wainwright’s price target suggests a potential upside of 227.38% from the stock’s current price.

QSI has been the topic of several other reports. National Bankshares set a $3.65 target price on Quantum-Si in a report on Wednesday, March 5th. Alliance Global Partners reissued a “buy” rating on shares of Quantum-Si in a research note on Friday.

Quantum-Si Trading Up 19.1%

NASDAQ:QSI opened at $1.68 on Monday. The business’s fifty day moving average price is $1.29 and its 200 day moving average price is $1.60. The firm has a market capitalization of $307.68 million, a price-to-earnings ratio of -2.63 and a beta of 2.71. Quantum-Si has a 1-year low of $0.61 and a 1-year high of $5.77.

Quantum-Si (NASDAQ:QSI) last issued its earnings results on Thursday, May 15th. The company reported ($0.11) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.17) by $0.06. The company had revenue of $0.84 million for the quarter, compared to the consensus estimate of $0.96 million. Quantum-Si had a negative return on equity of 36.96% and a negative net margin of 3,968.84%. Equities analysts forecast that Quantum-Si will post -0.65 earnings per share for the current year.

Insider Buying and Selling at Quantum-Si

In related news, CEO Jeffrey Alan Hawkins sold 23,707 shares of the stock in a transaction dated Friday, March 21st. The shares were sold at an average price of $1.39, for a total value of $32,952.73. Following the completion of the sale, the chief executive officer now owns 2,646,716 shares in the company, valued at approximately $3,678,935.24. This trade represents a 0.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders sold 36,650 shares of company stock worth $50,944 over the last ninety days. Company insiders own 30.04% of the company’s stock.

Institutional Trading of Quantum-Si

Hedge funds have recently modified their holdings of the company. Barclays PLC raised its stake in shares of Quantum-Si by 210.5% in the third quarter. Barclays PLC now owns 196,826 shares of the company’s stock valued at $173,000 after purchasing an additional 133,438 shares in the last quarter. SG Americas Securities LLC increased its holdings in Quantum-Si by 12.4% in the 4th quarter. SG Americas Securities LLC now owns 67,588 shares of the company’s stock valued at $182,000 after buying an additional 7,470 shares during the period. Abel Hall LLC acquired a new position in shares of Quantum-Si in the 4th quarter valued at $28,000. Rhumbline Advisers boosted its position in shares of Quantum-Si by 3.7% during the 4th quarter. Rhumbline Advisers now owns 148,946 shares of the company’s stock valued at $402,000 after acquiring an additional 5,298 shares in the last quarter. Finally, Sanctuary Advisors LLC acquired a new stake in shares of Quantum-Si during the 4th quarter valued at about $95,000. Institutional investors own 39.90% of the company’s stock.

About Quantum-Si

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.